Recent Trends in Computational Research on Diseases

Edited by
March 2022
130 pages
  • ISBN978-3-0365-3230-1 (Hardback)
  • ISBN978-3-0365-3231-8 (PDF)

This book is a reprint of the Special Issue Recent Trends in Computational Research on Diseases that was published in

Biology & Life Sciences
Medicine & Pharmacology
Public Health & Healthcare

Recent advances in information technology have brought forth a paradigm shift in science, especially in the biology and medical fields. Statistical methodologies based on high-performance computing and big data analysis are now indispensable for the qualitative and quantitative understanding of experimental results. In fact, the last few decades have witnessed drastic improvements in high-throughput experiments in health science, for example, mass spectrometry, DNA microarray, next generation sequencing, etc. Those methods have been providing massive data involving four major branches of omics (genomics, transcriptomics, proteomics, and metabolomics). Information about amino acid sequences, protein structures, and molecular structures are fundamental data for the prediction of bioactivity of chemical compounds when screening drugs. On the other hand, cell imaging, clinical imaging, and personal healthcare devices are also providing important data concerning the human body and disease. In parallel, various methods of mathematical modelling such as machine learning have developed rapidly. All of these types of data can be utilized in computational approaches to understand disease mechanisms, diagnosis, prognosis, drug discovery, drug repositioning, disease biomarkers, driver mutations, copy number variations, disease pathways, and much more. In this Special Issue, we have published 8 excellent papers dedicated to a variety of computational problems in the biomedical field from the genomic level to the whole-person physiological level.

  • Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
water temperature; bathing; ECG; heart rate variability; quantitative analysis; t-test; hypertrophic cardiomyopathy; data mining; automated curation; molecular mechanisms; atrial fibrillation; sudden cardiac death; heart failure; left ventricular outflow tract obstruction; cardiac fibrosis; myocardial ischemia; compound–protein interaction; Jamu; machine learning; drug discovery; herbal medicine; data augmentation; deep learning; ECG quality assessment; drug–target interactions; protein–protein interactions; chronic diseases; drug repurposing; maximum flow; adenosine methylation; m6A; RNA modification; neuronal development; genetic variation; copy number variants; disease-related traits; sequential order; association test; blood pressure; cuffless measurement; longitudinal experiment; plethysmograph; nonlinear regression; n/a